GENEVA, Nov. 17 -- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (HofgartenstraBe 880539 Munchen) filed a patent application (PCT/EP2025/062309) for "THERAPEUTIC VARIABLE DOMAIN OF HEAVY CHAIN (VHH) ANTIBODY FUSIONS CO-NEUTRALIZING ALPHA- AND GAMMA-HEMOLYSINS FROM STAPHYLOCOCCUS AUREUS " on May 06, 2025. With publication no. WO/2025/233321, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GORLICH, Dirk (c/o Max-Planck-Institut fur Multidisziplinare Naturwissenschaften, Am FaBberg 1137070 Gottingen), AKSU, ...